Expanding Access to CAR T-Cell Therapy in R/R Myeloma Care
Project Oncology®Expanding Access to CAR T-Cell Therapy in R/R Myeloma Care
Optimizing Care for Older Adults With FLT3-Mutated AML
On the Frontlines of AML/ALLOptimizing Care for Older Adults With FLT3-Mutated AML
ATTRibute-CM Findings on Acoramidis and Cumulative CV Events
On the Frontlines of ATTR-CMATTRibute-CM Findings on Acoramidis and Cumulative CV Events
How the 2025 IMWG Guidelines are Reshaping Sequencing in R/R Multiple Myeloma
Project Oncology®How the 2025 IMWG Guidelines are Reshaping Sequencing in R/R Multiple Myeloma
Redefining ATTR Treatment: Key Mechanisms and Emerging Data
Heart MattersRedefining ATTR Treatment: Key Mechanisms and Emerging Data
ATTRibute-CM Trial Updates: Long-Term Outcomes With Acoramidis
On the Frontlines of ATTR-CMATTRibute-CM Trial Updates: Long-Term Outcomes With Acoramidis
- advertisement
A New Paradigm in IgAN Management—Advancing Clinical Practice in the Era of Therapeutic Expansion
CME/CEA New Paradigm in IgAN Management—Advancing Clinical Practice in the Era of Therapeutic Expansion
Advancing Clinical Expertise in CELMoDs: Transforming Multiple Myeloma Treatment
CME/CEAdvancing Clinical Expertise in CELMoDs: Transforming Multiple Myeloma Treatment
Optimizing the Role for Corticosteroids Within the Evolving DMD Treatment Landscape
CME/CEOptimizing the Role for Corticosteroids Within the Evolving DMD Treatment Landscape
Bronchiectasis Update: Diagnostic Innovations and Therapeutic Frontiers
CME/CEBronchiectasis Update: Diagnostic Innovations and Therapeutic Frontiers
Identifying a Key Cause of Hard to Control Diabetes
CME/CEIdentifying a Key Cause of Hard to Control Diabetes
Treatment of a Broader Population of Patients With DMD
CME/CETreatment of a Broader Population of Patients With DMD
- advertisement
Rewiring Your Thinking in Paroxysmal Nocturnal Hemoglobinuria
Medical Industry FeatureRewiring Your Thinking in Paroxysmal Nocturnal Hemoglobinuria
Moving Beyond Hesitation: Exploring an Oral Option for Managing PNH
Medical Industry FeatureMoving Beyond Hesitation: Exploring an Oral Option for Managing PNH
Personalizing PNH Care: Exploring the Role of Iptacopan in Clinical Practice
Medical Industry FeaturePersonalizing PNH Care: Exploring the Role of Iptacopan in Clinical Practice
Navigating IgA Nephropathy: Pathogenesis, The Role Of APRIL & The 4-Hit Process, & A Patient Case Study
Medical Industry FeatureNavigating IgA Nephropathy: Pathogenesis, The Role Of APRIL & The 4-Hit Process, & A Patient Case Study
Expert Opinions on Characteristics of Patients With C3G at High Risk of Progression
Medical Industry FeatureExpert Opinions on Characteristics of Patients With C3G at High Risk of Progression
Expert Opinions on Characteristics of Patients With IgA Nephropathy (IgAN) at High Risk of Progression
Medical Industry FeatureExpert Opinions on Characteristics of Patients With IgA Nephropathy (IgAN) at High Risk of Progression